Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs DrMedHealth

Alan Meds
Graded #98

Higher grade

vs+4.8999999999999915
DrMedHealth
Graded #195

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 66.2/100.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +18
72
54
Dose & formulationDrMedHealth +2
75
77
Clinical oversightEven
82
82
Labs & monitoringEven
53
53
FulfillmentAlan Meds +7
78
71
Contract termsEven
55
55
Alan Meds · left barDrMedHealth · right bar

The numbers

MetricAlan MedsDrMedHealth
WeighScore71.1/10066.2/100
GradeCC
Scorecard rank#98#195
Semaglutide$158/mo (compounded)$199/mo (starting dose, compounded)
Tirzepatide$295/mo (compounded)$299/mo (starting dose, compounded)
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Alan Meds

Graded #98 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
DrMedHealth

Graded #195 · C

Strengths

  • LegitScript certified telehealth platform
  • Low compounded pricing: semaglutide from $199/mo, tirzepatide from $299/mo
  • Both compounded and FDA-approved branded options available
  • Fast physician review (advertised ~2 hours) with free shipping
  • Compounded by licensed US pharmacies

Where it loses points

  • Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
  • Cash-pay model; insurance generally not accepted for medication
  • Full list of available states not consolidated in one place
  • Site is JavaScript-rendered, limiting easy review of full terms

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard